CELLS possess multiple pathways to respond to the varied types of DNA damage that are caused by both endogenous and exogenous sources. Homologous recombination (HR) is a DNA damage repair/tolerance pathway with the potential to target a variety of DNA lesions, including single-stranded DNA (ssDNA) gaps and double-stranded DNA breaks (DSBs) ([@bib27]). HR requires the presence of intact homologous DNA donor sequences that serve as templates for the repair or bypass of DNA lesions. For DSBs to be channeled to HR, the broken ends must initially be resected to generate long stretches of 3′ overhang ssDNA ([@bib57]). The resulting ssDNA is subsequently coated with [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) protomers forming a nucleoprotein filament that carries out two key HR reactions: homology search and DNA strand invasion ([@bib56]). The invading ssDNA 3′ end primes DNA synthesis using the invaded duplex DNA as a repair template ([@bib35]). The resulting extended displacement loop structure (D-loop) may then be channeled to one of two main subpathways: synthesis-dependent strand annealing (SDSA) or the double Holliday junction (dHJ) pathway ([@bib24]). While SDSA produces exclusively noncrossover (NCO) repair products, the dHJ pathway has the potential to produce either crossover (CO) or NCO products depending on how the dHJ intermediate is processed.

Misregulation of HR can lead to genomic rearrangements and overall genomic instability despite its important role in DNA repair. To maintain genome stability, the HR pathway is tightly controlled and regulated at multiple steps. Since [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament formation is a crucial step in initiating the key HR functions of homology search and strand invasion, there has been a strong focus on HR regulation at the early stages of [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament assembly and disassembly. To regulate [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filaments, cells possess protein factors that help stabilize [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filaments as well as factors that help destabilize them ([@bib19]).

[Srs2](http://www.yeastgenome.org/locus/S000003628/overview) helicase is a member of the Superfamily 1 UvrD group of DNA helicases conserved from bacteria to mammals ([@bib48]; [@bib39]). [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) is a paradigmatic antirecombinase that acts by disrupting [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filaments ([@bib28]; [@bib59]). This antirecombination activity of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) is well supported by genetic evidence ([@bib49]; [@bib2]; [@bib11]; [@bib15]), as well as biochemical evidence that shows [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) can efficiently disrupt [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filaments *in vitro* ([@bib28]; [@bib59]). Single-molecule experiments directly visualized the processive dissociation of [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) from ssDNA at a rate of ∼50 [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) protomers per second ([@bib25]). Efficient [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-mediated disruption of [Rad51](http://www.yeastgenome.org/locus/S000000897/overview)--ssDNA filament requires [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) ATPase activity, suggesting that [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) directly regulates the [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) ATPase ([@bib4]; [@bib25]). Several biochemical and biophysical studies have shown that blocking the physical interaction between [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) and [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) prevents [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) from efficiently disrupting [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filaments *in vitro* including using the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902)* mutant protein ([@bib4]; [@bib13]; [@bib52]; [@bib25]). However, genetic and cytological studies of [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction-deficient *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)* mutants such as *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902)* have found no evidence to support the importance of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) physical interaction in antirecombination *in vivo* ([@bib13]; [@bib10]; [@bib50]). Despite exhibiting significant defects in [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption *in vitro*, *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902)* does not suppress *[rad18](http://www.yeastgenome.org/locus/S000000662/overview)Δ* DNA damage sensitivity ([@bib13]), a genetic interaction that is used as an indirect indicator of defects in [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination activity. Furthermore, meiotic overexpression of wild type (WT) and *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902)*, unlike helicase-deficient *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-K41A*, efficiently removes [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) foci from chromosomes, further indicating that the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction mediated by [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) residues 875--902 may be dispensable for [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination function *in vivo* ([@bib50]). This apparent discrepancy between the *in vitro* and *in vivo* studies may be because of a protein factor/modification missing from the *in vitro* biochemical reactions that is present *in vivo* which may have a greater impact on [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) [Rad51](http://www.yeastgenome.org/locus/S000000897/overview)-filament disruption activity than on the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction. One such factor could be [Rad52](http://www.yeastgenome.org/locus/S000004494/overview), which is not only required for the nucleation of [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filaments on ssDNA but also to protect [Rad51](http://www.yeastgenome.org/locus/S000000897/overview)--ssDNA filament against dissociation by [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) ([@bib34]).

[Srs2](http://www.yeastgenome.org/locus/S000003628/overview) has also been shown to promote formation of NCO repair products ([@bib22]; [@bib47]; [@bib61]; [@bib37]; [@bib38]), at least in part, by unwinding extended D-loops to promote the SDSA subpathway in HR ([@bib30]; [@bib44]). One proposed mechanism suggests that [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) and other enzymes such as human RECQL5 may promote SDSA through its [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption activity by removing [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) from the second end of the break, thus facilitating the annealing of the newly synthesized strand to the second resected end ([@bib22]; [@bib37]; [@bib40]). This hypothesis would predict that any mutation that affects the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination function would also affect the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function. Alternatively, [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function may rely on another unique biochemical activity separate from its well-characterized [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption activity. One such activity could be its ability to unwind extended D-loops, which would promote the SDSA pathway and the formation of NCO repair products ([@bib22]; [@bib14]; [@bib30]; [@bib44]).

Here, we identify a putative BRC repeat motif (residues 891--894) within the previously mapped [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction domain (residues 862--914). We find that mutating F891 within this motif weakens the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) physical interaction. Interestingly, *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* promotes a robust shift from NCO to CO repair products in a gap repair assay without any measurable effect on overall repair efficiency. This shift toward CO repair products suggests the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation may be interfering with the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function ([@bib6]; [@bib22]; [@bib37]). However, *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* does not exhibit a shift toward CO repair in an ectopic physical recombination system. Therefore, the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation interferes with the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function only under specific circumstances. Furthermore, despite its weakened interaction with [Rad51](http://www.yeastgenome.org/locus/S000000897/overview), *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* does not affect [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination function as examined both *in vivo* and *in vitro*. Our findings suggest that the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation, under certain circumstances, selectively disrupts the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function without affecting its antirecombination activity, which in turn argues in favor of the idea that the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function may be dictated by a biochemical activity separate and unique from its [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption activity. These findings further highlight the complexity of the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) C-terminal [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction domain, suggesting this region includes sites with very specific effects on [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) function.

Materials and Methods {#s1}
=====================

Yeast two-hybrid assays {#s2}
-----------------------

Full-length, WT budding yeast *[Srs2](http://www.yeastgenome.org/locus/S000003628/overview)* coding DNA was cloned into the yeast 2-hybrid prey vector (pJG4-5) in frame with the B42 activation domain and an HA tag using *Eco*RI and *Xho*I restriction sites. The *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutant allele was constructed via site-directed mutagenesis using pJG4-5-[Srs2](http://www.yeastgenome.org/locus/S000003628/overview) as a template. Full-length budding yeast *[RAD51](http://www.yeastgenome.org/locus/S000000897/overview)* was cloned into 2-hybrid bait vector (pEG202) in frame with the LexA domain using *Eco*RI and *Xho*I restriction sites. To prevent translation past the B42 and LexA domains in pJG4-5 and pEG202 negative control vectors, in-frame stop codons were introduced at the *Eco*RI sites. The list of plasmids used is found in Supplemental Material, Table S1 in File S1.

Budding yeast EGY48 strain (see Table S2 in File S1 for a list of all *Saccharomyces cerevisiae* strains used) was transformed with pSH18-34 LacZ reporter plasmid, as well as prey and bait vectors as indicated in [Figure 1C](#fig1){ref-type="fig"}. The resulting strains were grown on selective media and β-galactosidase activity measured in Miller units as previously described ([@bib18]).

![Mutations targeting the putative Srs2 BRC repeat-like motif weaken the Srs2--Rad51 physical interaction. (A) Schematic of Srs2 domains. (B) Sequence alignment of the putative Srs2 BRC repeat motif with other BRC repeat motifs in the indicated species. Glycine (G): orange; phenylalanine (F), isoleucine (I), leucine (L), alanine (A): blue; serine (S), threonine (T): green; proline (P): yellow; aspartic acid (D), glutamic acid (E): violet. (C) Quantitative β-galactosidase assay analyzing the physical interaction between full-length Srs2 and Rad51. (D) Ni-NTA pull-down with 1.3 μM Rad51 and 0.4 μM His9-tagged Srs2 (WT or srs2-F891A) at increasing concentrations of KCl (0--400 mM). Srs2 was visualized using a Biorad stain-free imaging system. Rad51 bands were detected by immunoblot analysis. The amount of Rad51 pulled down was normalized against the amount of Srs2 pull-down in each lane. Shown are means ±1 SE, *n* = 2--3.](1133f1){#fig1}

DNA damage sensitivity {#s3}
----------------------

For the quantitative UV survival assay, yeast strains (Table S2 in File S1) were grown overnight rotating at 30° and then diluted appropriately and plated onto YPD, followed by UV irradiation at the indicated doses (Spectrolinker, XL-1500 UV cross-linker). The plates were incubated at 30° for 2 days. The number of colonies in UV-treated cells was compared to that of untreated controls. For quantitative the gamma-irradiation sensitivity assay, log phase cultures of strains were diluted and plated onto YPD followed by *gamma radiation* from a *cesium*-137 source at the indicated doses. The plates were then incubated for 2 days at 25°. Room temperature (25°) incubation was selected because *[rad55](http://www.yeastgenome.org/locus/S000002483/overview)Δ* strains are known to be cold-sensitive ([@bib33]). The number of colonies in gamma-irradiated strains was compared to untreated controls.

For the serial dilution assays, the OD~600~ of overnight yeast cultures was adjusted to 2.0, followed by six fivefold serial dilutions. 2 μl of each dilution was spotted in order onto YPD plates with or without DNA damage induction.

DSB repair efficiency, crossover frequency, and recombination rate analyses {#s4}
---------------------------------------------------------------------------

Gap repair, ectopic physical recombination, and spontaneous inverted repeat assays were carried out as previously described ([@bib22]; [@bib54]; [@bib37]). To generate the radioactive probe for the ectopic physical recombination assay, the following two primers were used: 5′-TGGATGATATTTGTAGTATGGCGG-3′ and 5′-CCGCATGGGCAGTTTACCT-3′.

Protein purification, affinity pull-down assay, immunoblots {#s5}
-----------------------------------------------------------

*S. cerevisiae* His9-tagged wild type and *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* were purified to near homogeneity from *Escherichia coli* (Figure S1 in File S1), and native [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) was purified from the cognate host as described ([@bib30]). Pull-downs were conducted as previously described with 1.34 μM [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) and 0.424 μM His9-tagged [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) at the indicated concentrations of KCl ([@bib13]). The resulting eluates were analyzed on 4--20% Mini-PROTEAN TGX Stain-Free Protein Gels (Biorad, Hercules, CA). [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) bands were visualized by activating the stain-free gel by exposure to 1 min of UV transillumination with the ChemiDoc Touch (Biorad). [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) bands were visualized using immunoblot analysis with rabbit anti-[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) serum (a generous gift from Dr. Akira Shinohara). The band intensities were analyzed using ImageJ software.

To examine the interaction between [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) and [Rad55](http://www.yeastgenome.org/locus/S000002483/overview), 200 nM purified GST--[Rad55](http://www.yeastgenome.org/locus/S000002483/overview)--His6--[Rad57](http://www.yeastgenome.org/locus/S000002411/overview) or 200 nM GST (GE Healthcare) were incubated with 50 nM purified His9-tagged [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) (WT or F891A) in buffer K (20 mM potassium phosphate pH 7.4, 10% glycerol, 0.5 mM EDTA, 0.01% NP-40 alternative, 1 mM DTT) with 150 mM NaCl for 1 hr at room temperature. Eighty microliters of preequilibrated and BSA-blocked Glutathione Sepharose 4B bead slurry was added to the protein mixtures and incubated while mixing for an additional 1.5 hr at room temperature. The beads were centrifuged and washed twice with 150 μl of K buffer. The pulled-down protein complexes were eluted off the beads by boiling the beads in 25 μl of 2× Laemmli sample buffer (26.3% glycerol, 65.8 mM Tris-Cl pH 6.8, 2.1% SDS, 0.01% bromophenol blue, 710 mM β-mercaptoethanol) for 5 min. The resulting eluate was loaded on 4--20% Mini-PROTEAN TGX Precast Protein Gels (Biorad). The protein bands were visualized through immunoblot analysis using anti-[Srs2](http://www.yeastgenome.org/locus/S000003628/overview) (sc11991; Santa Cruz Biotechnology) and anti-[Rad55](http://www.yeastgenome.org/locus/S000002483/overview) ([@bib7]) antibodies.

Whole protein was extracted from wild-type, *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A*, and *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆* strains using the trichloroacetic acid (TCA) extraction protocol described in Clontech Yeast Protocols Handbook (Protocol No. PT3024-1, Version No. PR973283). For protein detection by immunoblotting, TCA whole cell extracts were separated by SDS-PAGE and analyzed by immunoblotting using anti-PGK1 (ab197960; Abcam) and anti-[Srs2](http://www.yeastgenome.org/locus/S000003628/overview) (sc11991; Santa Cruz Biotechnology) antibodies.

ATPase assay {#s6}
------------

A coupled spectrophotometric ATPase assay was performed as described previously with minor modifications ([@bib31]). Reactions were carried out in 35 mM Tris-acetate pH 7.5, 100 mM NaCl, 7 mM magnesium acetate, 2 mM ATP, 1 mM DTT, 0.25 mg/ml BSA, and an ATP regenerating system \[30 U/ml pyruvate kinase (Sigma, St. Louis, MO), 3 mM phosphoenolpyruvate (Sigma), and 0.3 mg/ml NADH (Sigma)\], in the presence or absence of 10 μM (in nucleotides) φX174 ssDNA cofactor. Purified [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) WT or F891A (5 nM) was added to initiate the reactions at 30°. ATP hydrolysis rates were estimated from the measured changes in absorbance at 340 nm within the linear portions of time courses.

D-loop disruption assay {#s7}
-----------------------

The D-loop disruption assay was carried out as recently described ([@bib30]).

Assay for Rad51 filament disruption {#s8}
-----------------------------------

A 5′-biotinylated 100-mer with sequence 5′-ATGTCTAATATTCAAACTGGCGCCGAGCGTATGCCGCATGACCTTTCCCATCTTGGCTTCCTTGCTGGTCAGATTGGTCGTCTTATTACCATTTCAACTA-3′ was immobilized onto magnetic streptavidin beads (M-280; Thermo Fisher) as described by [@bib32]). Two μl of suspended beads were incubated with 1 μM nucleotides ssDNA and agitated with 300 nM [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) in 10 μl reaction buffer (35 mM Tris-acetate, 7 mM magnesium acetate, 4 mM ATP, 50 μg/ml BSA, and 1 mM DTT) for 20 min. Beads were washed with reaction buffer to remove free [Rad51](http://www.yeastgenome.org/locus/S000000897/overview). Beads were then agitated with 10 μl of reaction buffer with or without 25 nM [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) or [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A for 20 min. Nucleotides (100 μM) of noncomplementary scavenger DNA with the sequence 5′-CTTGCTGAATATATCTGGAAGTATTATGCAGATTCATTATTCGAAGGGGGAGGCGGGGGTGGAAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTA-3′ were added and further incubated for 10 min. Supernatant containing unbound proteins was collected and tested for the amount of [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) by immunoblot analysis with mouse anti-[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) (sc-133089; Santa Cruz Biotechnology) antibody using a 1:500 dilution. All steps were carried out at 30°.

Data availability {#s9}
-----------------

Strains and plasmids are available upon request. Table S1 lists the two-hybrid plasmids used. Table S2 lists the *S. cerevisiae* strains used. Figure S1 shows the purified [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A protein. Figure S2 shows the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-[Rad55](http://www.yeastgenome.org/locus/S000002483/overview) interaction data. Figure S3 shows ATPase data. Figure S4 shows DNA damage sensitivity data. Figure S5 shows tetrad data for absence of synthetic lethalities. Supplemental material available at FigShare: <https://doi.org/10.25386/genetics.8179493>.

Results {#s10}
=======

The Rad51 interaction domain of Srs2 contains a BRC repeat motif {#s11}
----------------------------------------------------------------

Human RECQL5, a potential functional homolog of yeast [Srs2](http://www.yeastgenome.org/locus/S000003628/overview), was previously proposed to possess a BRC repeat motif mediating its interactions with [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) much like the interaction between BRCA2 and [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) ([@bib23]). In fact, the authors also reported finding BRC repeat-like motifs in other known yeast HR proteins such as [Srs2](http://www.yeastgenome.org/locus/S000003628/overview), [Mph1](http://www.yeastgenome.org/locus/S000001441/overview), [Sgs1](http://www.yeastgenome.org/locus/S000004802/overview), and [Pif1](http://www.yeastgenome.org/locus/S000004526/overview) ([@bib23]). The [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) BRC repeat motif previously proposed by [@bib23] spans amino acids 837 through 840 ([F]{.ul}TAA). However, [srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F837A mutant protein exhibited no [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction defect, even though, at low concentrations, it exhibited a slight decrease in inhibiting D-loop formation *in vitro* ([@bib23]). This prompted us to look further within the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) sequence for other potential BRC repeat motifs. We particularly focused our search on amino acids 875 through 902, a region whose deletion (*[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902)*) has been shown to effectively disrupt [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) physical interaction *in vitro* ([@bib13]). We identified residues 891--894, FHSP, as a potential BRC repeat motif ([Figure 1A](#fig1){ref-type="fig"}). Even though BRC repeat motifs typically have an alanine at the fourth site, there is precedence for a proline at this position in the *Gallus gallus* BRC5 repeat motif ([@bib60]) ([Figure 1B](#fig1){ref-type="fig"}).

srs2-F891A exhibits reduced interaction with Rad51 {#s12}
--------------------------------------------------

Crystallographic data have shown that the phenylalanine in a BRC repeat functions as a hydrophobic key that is wedged into a hydrophobic [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) pocket ([@bib43]). We, therefore, mutated F891 to alanine to eliminate this potential hydrophobic interaction without significantly altering the overall charge and polarity. We used yeast 2-hybrid assays to examine how the predicted BRC repeat region affects the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction. The analysis shows that mutating F891 to alanine greatly reduces the interaction between [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) and [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) ([Figure 1C](#fig1){ref-type="fig"}). To further examine the [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction defect conferred by the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation, we purified His9-tagged WT [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) and [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A from *E. coli* to near homogeneity (Figure S1 in File S1) and tested the physical interaction with [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) ([Figure 1D](#fig1){ref-type="fig"}). We found that compared to WT [Srs2](http://www.yeastgenome.org/locus/S000003628/overview), [srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A showed a consistent decrease in [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction *in vitro* over a range of salt concentrations ([Figure 1D](#fig1){ref-type="fig"}).

To verify that the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation does not cause overall misfolding that blocks all protein interactions, we tested its interaction with another known [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) interacting protein, [Rad55](http://www.yeastgenome.org/locus/S000002483/overview) ([@bib32]). We found that [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A is just as adept as WT [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) in interacting with [Rad55](http://www.yeastgenome.org/locus/S000002483/overview) (Figure S2 in File S1) at a salt concentration (150 mM) that caused a significant reduction in [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction with [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A ([Figure 1D](#fig1){ref-type="fig"}). The intact [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A-[Rad55](http://www.yeastgenome.org/locus/S000002483/overview) interaction indicates that this mutant [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) is not grossly misfolded.

To further assess whether [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A mutation affects protein folding and stability, we compared its endogenous protein expression levels to that of wild-type [Srs2](http://www.yeastgenome.org/locus/S000003628/overview). Generally, misfolded proteins are associated with a reduction in protein stability that translates into lower steady-state protein levels. We found WT [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) and [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A are expressed to the same steady-state level, further indicating [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A mutant protein is properly folded ([Figure 2D](#fig2){ref-type="fig"}).

In accordance with these findings, purified mutant [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A protein exhibits levels of ATPase activity comparable to that of WT [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) (Figure S3 in File S1).

srs2-F891A mutant is proficient at antirecombination *in vivo* {#s13}
--------------------------------------------------------------

The observation that [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A is defective in [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction would suggest that it is also defective in [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption, and consequently, antirecombination. To investigate the antirecombination effects of the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation *in vivo*, we examined sensitivity of the mutant to various DNA-damaging agents. The *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutant displayed no statistically significant or reproducible sensitivity to ultraviolet light (UV), ionizing radiation (IR), or methyl methanesulfonate (MMS) beyond that observed in WT strains ([Figure 2, A--C](#fig2){ref-type="fig"} and Figure S4 in File S1). Moreover, we investigated its genetic interactions with *[rad55](http://www.yeastgenome.org/locus/S000002483/overview)Δ* and *[rad18](http://www.yeastgenome.org/locus/S000000662/overview)Δ*, whose DNA damage sensitivity is suppressed by *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)Δ* ([@bib29]; [@bib49]; [@bib32]). The observed suppression in the double deletion mutants, *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)Δ [rad55](http://www.yeastgenome.org/locus/S000002483/overview)Δ* and *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)Δ [rad18](http://www.yeastgenome.org/locus/S000000662/overview)Δ*, are attributed to loss of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination activity. While the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆* mutation partially suppressed the *[rad55](http://www.yeastgenome.org/locus/S000002483/overview)∆* IR sensitivity as expected ([@bib32]), we observed no suppression of *[rad55](http://www.yeastgenome.org/locus/S000002483/overview)∆* IR sensitivity in *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutant background ([Figure 2B](#fig2){ref-type="fig"}), further suggesting that *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* is proficient at antirecombination *in vivo*.

![*srs2-F891A* mutation has no effect on UV sensitivity, *rad55∆* IR sensitivity, or *rad18∆* MMS sensitivity. (A) Quantitative UV survival assay. The indicated haploid W303 strains were grown to stationary phase in liquid YPD medium, plated onto YPD, UV irradiated, and then grown at 30° for 2 days. The number of surviving colonies was normalized to the number of viable colonies in the unirradiated control samples. (B) Quantitative IR survival assay. The indicated haploid W303 strains were grown to midlog phase, irradiated with IR (0--200 Gy), and then plated onto YPD and grown at 25° for 2 days. *srs2-F891A*, unlike *srs2∆*, does not suppress *rad55∆* IR sensitivity. (C) Qualitative MMS survival assay. Strains were grown to stationary phase in liquid YPD. Serial fivefold dilutions of the strains were then spotted onto YPD or 0.0006% MMS and grown at 30° for 1 day. The *srs2∆ rad18∆* double mutant appears white because it is *ADE2*+ unlike the other strains depicted. *srs2∆* suppresses *rad18∆* MMS sensitivity as expected. (D) Immunoblot analysis of whole cell protein TCA extraction of WT and *srs2-F891A* strains (W303 background). *srs2∆* was used as a negative control. Shown are means ±1 SE, *n* = 3.](1133f2){#fig2}

Early studies showed that *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)* suppresses the DNA damage sensitivities of *[rad6](http://www.yeastgenome.org/locus/S000003026/overview)* and *[rad18](http://www.yeastgenome.org/locus/S000000662/overview)* mutants ([@bib29]; [@bib49]), which represents the key phenotype of its antirecombination activity. [Rad18](http://www.yeastgenome.org/locus/S000000662/overview) is an E3 ubiquitin ligase that forms a functional complex with [Rad6](http://www.yeastgenome.org/locus/S000003026/overview), an E2 ubiquitin-conjugating enzyme. The [Rad6](http://www.yeastgenome.org/locus/S000003026/overview)-[Rad18](http://www.yeastgenome.org/locus/S000000662/overview) complex ubiquitylates [PCNA](http://www.yeastgenome.org/locus/S000000292/overview); the ubiquitylated [PCNA](http://www.yeastgenome.org/locus/S000000292/overview), in turn, recruits translesion synthesis (TLS) polymerases to bypass damaged nucleotides ([@bib20]; [@bib8]). As expected, mutations affecting *[RAD18](http://www.yeastgenome.org/locus/S000000662/overview)* or *[RAD6](http://www.yeastgenome.org/locus/S000003026/overview)* exhibit significant DNA damage sensitivity. *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆* suppresses both *[rad6](http://www.yeastgenome.org/locus/S000003026/overview)* and *[rad18](http://www.yeastgenome.org/locus/S000000662/overview)* damage sensitivity by allowing HR-mediated repair to be substituted for TLS-mediated DNA damage tolerance. We hypothesized that if *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation affected the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination activity, then *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* should also suppress *[rad18](http://www.yeastgenome.org/locus/S000000662/overview)∆* MMS sensitivity. Based on our findings, however, *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* does not suppress *[rad18](http://www.yeastgenome.org/locus/S000000662/overview)∆* DNA damage sensitivity, further supporting the idea that this mutant is proficient at antirecombination ([Figure 2C](#fig2){ref-type="fig"}).

In addition to damage sensitivity, we also investigated *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* genetic interactions with *[sgs1](http://www.yeastgenome.org/locus/S000004802/overview)Δ* and *[rad54](http://www.yeastgenome.org/locus/S000003131/overview)Δ*, which exhibit synthetic growth defect and synthetic lethality with *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)Δ*, genetic interactions linked to loss of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination function. These negative genetic interactions have been attributed to the accumulation of toxic recombination intermediates due to the absence of the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombinase activity ([@bib41]; [@bib16]). Neither *[rad54](http://www.yeastgenome.org/locus/S000003131/overview)∆ [srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* nor *[sgs1](http://www.yeastgenome.org/locus/S000004802/overview)∆ [srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* double mutants exhibit any synthetic lethality or growth defects (Figure S5 in File S1).

srs2-F891A mutant is proficient at antirecombination *in vitro* {#s14}
---------------------------------------------------------------

The importance of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction in [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination activity has primarily been demonstrated *in vitro* and not *in vivo*. Several studies have shown that blocking the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction prevents [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) from disrupting [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filaments *in vitro* ([@bib4]; [@bib13]; [@bib52]). We, therefore, tested whether [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A would exhibit a similar defect in [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption *in vitro*. We examined the [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption activity of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A *in vitro* using magnetic beads coupled with ssDNA and bound by [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) ([Figure 3A](#fig3){ref-type="fig"}) ([@bib23]). Addition of either [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) or [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A was associated with a comparable increase in the amount of [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) bound to scavenger DNA, indicative of no defect in [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption with [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A ([Figure 3, B and C](#fig3){ref-type="fig"}).

![Srs2-F891A and Srs2 disrupt Rad51 filaments at similar rates. *In vitro* disruption of Rad51 filaments. (A) A schematic of the assay where Rad51 filaments were assembled on ssDNA immobilized to magnetic beads and disrupted by Srs2 or Srs2-F891A. (B) Supernatant Rad51 bound to scavenger DNA with 25 nM of Srs2 or Srs2-F891A was analyzed by immunoblot. A representative blot is shown. (C) Quantification of supernatant Rad51 was normalized to fold increase over no Srs2 added. Shown are means ±1 SD, *n* = 3. The difference is not significant by a Student's *t*-test.](1133f3){#fig3}

In summary, both our genetic and biochemical observations suggest *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* is proficient at antirecombination both *in vivo* and *in vitro* despite the observed decrease in its [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction.

srs2-F891A exhibits a shift from NCO to CO repair products in plasmid-based gap repair {#s15}
--------------------------------------------------------------------------------------

The [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombinase activity has been shown to be dependent on the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) physical interaction, particularly *in vitro* ([@bib4]; [@bib13]; [@bib52]). However, other studies have also shown [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) to play an important role in CO control ([@bib6]; [@bib22]; [@bib47]; [@bib14]; [@bib37]; [@bib38]). Interestingly, more recently, the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) physical interaction has also been implicated in regulating SDSA-mediated repair ([@bib38]). Removal of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) amino acid residues 860 through 998, a deletion that is expected to disrupt the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction, results in a subtle but statistically significant increase in SDSA repair efficiency in a plasmid-based repair assay ([@bib13]; [@bib38]). Conversely, however, deletion of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) amino acids 783--998 or 783--859, deletions also predicted to disrupt [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction, significantly *decreases* SDSA repair ([@bib28]; [@bib38]). Despite the conflicting results with the different [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) internal deletions, these findings suggested that the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction region also plays a role in SDSA regulation. Given the reduced [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction observed with [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A, we were particularly interested in examining how *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation might affect the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function.

To assess SDSA in *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A*, a previously developed plasmid-based gap repair assay was employed to determine whether *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* affects repair efficiency and CO to NCO ratios in a manner similar to *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆* ([Figure 4A](#fig4){ref-type="fig"}) ([@bib36], [@bib37]). The gap repair assay relies on the transformation of a linearized *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* ARS plasmid missing 8 bp from the middle of the 800-bp *[HIS3](http://www.yeastgenome.org/locus/S000005728/overview)* marker. A chromosomally integrated *[his3](http://www.yeastgenome.org/locus/S000005728/overview)* mutant allele with the last 11 codons missing is used as a repair template for the linearized plasmid. If the plasmid is repaired without associated CO events, then the plasmid is not integrated and thus, in the absence of selection, the *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* marker will persist only temporarily. However, if the plasmid repair is associated with a CO event, then the plasmid will be chromosomally integrated, thus leading to stable maintenance of the *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* marker. This gap repair system examines the frequency of His^+^ transformants, indicative of overall repair efficiency and CO to NCO ratios, by measuring the fraction of His^+^ transformants that possess a stable *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* marker. *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)Δ* showed a reduction in overall repair efficiency as previously reported ([@bib37]), but *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutants did not exhibit a significant change in overall gap repair efficiency ([Figure 4, B and C](#fig4){ref-type="fig"}). The *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutant did, however, display a statistically significant shift from NCO to CO repair products in two different strain backgrounds (W303 and SJR; [Figure 4, B and C](#fig4){ref-type="fig"}). It is important to note that the increase in CO frequency is not the result of lower [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A protein levels ([Figure 2D](#fig2){ref-type="fig"}). The CO to NCO ratios observed in the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutant closely resemble the ratios observed in *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆*, even though *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A*, unlike *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆*, exhibits no measurable defect in overall repair efficiency. This observation suggests the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation specifically disables [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA activity while leaving its antirecombination activity intact. This apparent separation-of-function mutation suggests that the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function may be independent of its well-documented [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption activity. This finding also suggests that the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891 residue mediating [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction may play a role in the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function.

![*srs2-F891A* (W303 strain background) increases the relative CO frequency without affecting overall repair efficiency. (A) Schematic of the gap repair system. Plasmid linearized within the *HIS3* reading frame was transformed into yeast strain where *his3∆3′* serves as the repair template for the linearized plasmid. The stable presence of the *URA3* marker was used as an indicator of plasmid integration, representing CO events, while the unstable presence of the *URA3* marker was used an indicator of plasmid repair without integration, representing NCO events. (B) Gap repair assay shows that *srs2-F891A* (W303 strain background) has no defect in repair efficiency but exhibits a clear shift from NCO repair products to CO repair products similar to *srs2∆*. All strains were MMR-defective (*mlh1∆*). Asterisks indicate a significant difference when compared to WT using a Student's *t*-test (*P* $\leq$ 0.05). (C) Gap repair analysis of *srs2-F891A* in SJR strain background recapitulates findings in the W303 strain background.](1133f4){#fig4}

Yeast [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) helicase, an ortholog of the human FANCM, has been shown to promote an NCO outcome, likely through its D-loop disruption activity observed *in vitro* ([@bib46]). We reasoned that if [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) and [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) have partially overlapping functions, then *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆ [srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* double mutants might exhibit a greater shift toward CO repair products than the single mutants. To test this, we examined the genetic interaction between *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆* and *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* in the gap repair system. *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆ [mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆* double mutants were excluded from the genetic analyses, because of their severe synthetic growth defects and poor spore viability ([@bib58]; [@bib12]; [@bib46]; [@bib42]). Similarly to *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A*, earlier studies showed that an *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆* mutant exhibits no gap repair deficiency despite a clear shift from NCO to CO repair products ([@bib37]). Our direct comparison of the two mutants in the W303 background confirms this observation ([Figure 4B](#fig4){ref-type="fig"}). Contrary to our expectation, the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A [mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆* double mutants exhibited no increased shift toward CO repair products beyond that observed in either single mutant ([Figure 4B](#fig4){ref-type="fig"}). However, the double mutants did have a synergistic defect in overall gap repair efficiency indicative of a genetic interaction between *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* and *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆* ([Figure 4B](#fig4){ref-type="fig"}). *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* and *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆* did not exhibit any synergistic survival defects in response to IR, UV, or MMS (Figure S4 in File S1). It is important to note that the gap repair assay used here is limited to analyzing repair products among the surviving cells. Therefore, it is possible that CO events may be disproportionately represented among dying cells, which may explain why the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A [mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆* double mutants do not show the expected synergistic increase in CO frequency. Altogether, our findings suggest that while [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) physical interaction as mediated by [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891 residue is not critical for the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination function, it may play an important role in SDSA/CO regulation in plasmid-based gap repair.

srs2-F891A exhibits wild-type NCO to CO ratios in an ectopic physical assay {#s16}
---------------------------------------------------------------------------

To confirm the plasmid-based gap repair findings and to better evaluate the state of repair among the nonsurviving cell populations, we used a previously designed ectopic physical recombination assay with 1.9-kb homology of 1.4 and 0.5 kb flanking the DSB ([Figure 5A](#fig5){ref-type="fig"}) ([@bib22]). We reproduced earlier findings showing an increase in CO frequency in *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆* and *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆* mutants ([@bib22]; [@bib62]). Surprisingly, this chromosome-based physical assay did not detect a measurable increase in CO frequency in the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutant ([Figure 5, B and C](#fig5){ref-type="fig"}). Even the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A [mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆* double mutant did not exhibit any further increase in CO frequency compared to that observed in the *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)∆* single mutant ([Figure 5, B and C](#fig5){ref-type="fig"}). In conclusion, even though the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutants in both W303 and SJR yeast strain backgrounds showed a clear and reproducible shift from NCO to CO repair products in the plasmid-based gap repair assay, the ectopic physical recombination assay did not detect a similar effect.

![Ectopic physical recombination assay. (A) Schematic of the ectopic physical recombination assay. (B) Representative Southern blot analysis of the CO and NCO repair products for the strains shown in the figure. (C) Quantitative analysis of the CO to NCO ratio. The lower CO band intensities were divided by the sum of the lower CO and NCO bands. In contrast to the gap repair system, the ectopic physical recombination assay does not exhibit a shift from NCO to CO repair products even in an *mph1∆* background. Shown are means ±1 SE, *n* = 3.](1133f5){#fig5}

srs2-F891A is proficient at spontaneous inverted repeat recombination {#s17}
---------------------------------------------------------------------

Since the physical recombination assay, unlike the plasmid-based gap repair assay, did not produce a phenotype for *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A*, we hypothesized the different outcomes in the two assays may be linked to the variable extents of sequence homology. Therefore, we tested the effects of the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation in a previously designed intron-based spontaneous inverted repeat assay that provides limited sequence homology (783 bp) and has previously detected a robust increase in recombination rate in *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆* mutants ([Figure 6A](#fig6){ref-type="fig"}) ([@bib53], [@bib55]). We compared the recombination rates of WT, *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆*, and *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* in the inverted repeat assay. We detected a robust, eightfold increase in *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆* recombination rates as previously reported; however, the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation did not significantly increase recombination rates ([Figure 6B](#fig6){ref-type="fig"}). This result confirms the retention of antirecombination activity in the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutant but does not provide insight into the differences between the gap repair and physical assays.

![Spontaneous inverted repeat assay. (A) Schematic of the intron-based inverted repeat recombination assay. Inverted repeats of cβ2 intron sequence (blue) are fused to intron splice sites (gray) positioned adjacent to the 5′ and 3′ halves of the *HIS3* gene (yellow). Spontaneous CO events at cβ2 intron sequence reorient and bring together the *his3* halves. The resulting transcript produces a functional HIS3 mRNA after splicing out the cβ2 intervening sequence. (B) Recombination rates for wild type and *srs2∆* recapitulate findings previously published ([@bib53], [@bib55]). *srs2-F891A* mutant exhibits rates of recombination comparable to that of the wild type.](1133f6){#fig6}

Srs2-F891A is proficient at dissolving stable Rad51-catalyzed D-loops *in vitro* {#s18}
--------------------------------------------------------------------------------

Given that *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* exhibited a robust shift toward CO repair products in the plasmid-based gap repair assay while maintaining intact antirecombination activities, we hypothesized that *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* may be specifically disabled in D-loop disruption, an activity which has only recently been observed *in vitro* ([@bib32]). To address this possibility, we reconstituted [Rad51](http://www.yeastgenome.org/locus/S000000897/overview)-catalyzed D-loops *in vitro* and challenged them with increasing concentrations of both WT and [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A mutant protein ([Figure 7A](#fig7){ref-type="fig"}). Surprisingly, despite the robust shift in favor of CO repair in the plasmid-based repair assay, the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A mutant protein showed no significant defect in D-loop disruption *in vitro* ([Figure 7, B and C](#fig7){ref-type="fig"}).

![Both Srs2-F891A and Srs2 dissolve the D-loop *in vitro*. (A) Schematic of the reconstituted D-loop disruption assay. (B) Representative gel of Srs2 and Srs2-F891A titration in D-loop disruption assay. (C) Quantification of D-loops in the presence of increasing concentrations of Srs2 and Srs2-F891A proteins. Shown are means ±1 SD, *n* = 3.](1133f7){#fig7}

Discussion {#s19}
==========

[Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-mediated [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption/antirecombination has long been proposed to require a physical interaction with [Rad51](http://www.yeastgenome.org/locus/S000000897/overview). This notion is largely supported by extensive biochemical studies which have shown that [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction-deficient *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)* mutants (C-terminal or internal deletions) are also deficient in [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption *in vitro*. However, genetic analyses of such [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction-deficient *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)* mutants are limited. Studies that have genetically and cytologically examined [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction-deficient *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)* mutants with small internal deletions have found little evidence for antirecombination defects *in vivo* ([@bib13]; [@bib10]; [@bib50]). By contrast, C-terminal deletions of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) that remove the [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction domain do exhibit antirecombination defects in genetic analyses. These defects, however, are likely because of the simultaneous deletion of the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) PIP-like motif (PCNA-interacting protein box spanning residues 1148--1161) as well as the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) SIM (Sumo interaction motif spanning residues 1168--1174) ([@bib13]; [@bib5]). To further examine the biological significance of the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) physical interaction, we identified and constructed a single point mutation in the *[Srs2](http://www.yeastgenome.org/locus/S000003628/overview)* C-terminal [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction region (*[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A*) that measurably reduces [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) binding *in vivo* and *in vitro*. Importantly, the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation, unlike the C-terminal and internal *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)* deletion mutations examined previously, appears to retain the overall integrity of the protein with minimal effects on other potential [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) functions, therefore reducing the likelihood of introducing confounding variables.

Based on our findings, [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A, despite its weakened interaction with [Rad51](http://www.yeastgenome.org/locus/S000000897/overview), does not exhibit defects in antirecombination in genetic analyses or when using *in vitro* assays. Our *in vivo* findings are consistent with the previous genetic analyses of [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction-deficient *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)* mutants ([@bib13]; [@bib10]; [@bib50]). However, our *in vitro* findings are more surprising and are discussed below.

Other groups have examined the role of the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction domain with respect to antirecombination *in vivo*. One study previously showed that deletion of a small region in [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) (residues 875--902) effectively blocks interactions with [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) ([@bib13]). It further showed that purified [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902) is unable to disrupt [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filaments. However, even though their biochemical findings clearly showed a strong decrease in the [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption activity of this [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) mutant, the authors found *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902)* does not suppress the *[rad18](http://www.yeastgenome.org/locus/S000000662/overview)∆* MMS or UV sensitivity ([@bib13]; [@bib10]). The suppression of the *[rad18](http://www.yeastgenome.org/locus/S000000662/overview)∆* DNA damage sensitivity by *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)∆* has been attributed to loss of the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination function such that [Rad51](http://www.yeastgenome.org/locus/S000000897/overview)-mediated repair can take the place of the [Rad18](http://www.yeastgenome.org/locus/S000000662/overview)-mediated postreplicative repair ([@bib29]; [@bib3]; [@bib1]; [@bib51]). To explain this inconsistency, the authors hypothesized that *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902)* failed to suppress *[rad18](http://www.yeastgenome.org/locus/S000000662/overview)∆* DNA damage sensitivity because [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902) mutant protein may still maintain residual interaction with [Rad51](http://www.yeastgenome.org/locus/S000000897/overview). Another group also investigated the *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902)* mutant in their cytological analyses and found that overexpression of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(875--902) during meiosis still effectively removed [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) foci *in vivo* ([@bib50]). The results reported here also suggest that the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction as mediated through [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) residue F891 may be dispensable for [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-mediated antirecombination *in vivo*. The apparent discrepancy between the *in vivo* and *in vitro* roles of the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction may be because *in vivo* there are other factors, such as [PCNA](http://www.yeastgenome.org/locus/S000000292/overview), that are equally, if not more, important for the recruitment of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) for [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption. In fact, a recent genetic study on *[SRS2](http://www.yeastgenome.org/locus/S000003628/overview)* concluded that the main role of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) in DNA repair depends on its helicase/translocase activity instead of its Rad51or [PCNA](http://www.yeastgenome.org/locus/S000000292/overview) interaction ([@bib9]).

While *in vivo* evidence supporting the biological significance of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction in antirecombination is lacking, there is extensive biochemical evidence that shows this interaction is required for [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption *in vitro* ([@bib4]; [@bib13]). Therefore, the robust [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption activity of *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A in vitro* was surprising. Several studies have examined various C-terminal deletions or small internal deletions of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) that abrogate its interaction with [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) and have found these mutant [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) proteins to be defective in [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption *in vitro* ([@bib4]; [@bib13]; [@bib52]). This contrasts with our findings for [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A. However, in contrast to the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A point mutant, these mutants involve deletions of at least 27 residues, which are expected to have more extensive effects on [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) function. Therefore, it is possible that the previous [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction-deficient *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)* mutants, given their larger deletion sizes, have more wide-ranging effects on [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) activity.

Only one other study has explored an *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)* single mutation (L844A) that measurably interferes with [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction; however, [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-L844A, unlike [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A, was shown to exhibit reduced [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) filament disruption compared to WT [Srs2](http://www.yeastgenome.org/locus/S000003628/overview), as extrapolated from D-loop assays ([@bib23]). Others have previously proposed that the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction is likely mediated by [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) residues clustered in separate regions within [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) residues 783--998 ([@bib26]). It is also possible that these separate [Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction regions affect different aspects of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) function, with the region around L844 mediating [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) antirecombination and the region around F891 mediating [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function.

As discussed earlier, the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction has been implicated in SDSA regulation ([@bib38]). In studies by Miura *et al.* SDSA repair efficiency was assayed in a gap repair assay that requires the invasion of two distinct ectopic donor alleles, thus limiting repair to SDSA ([@bib38]). Interestingly, the authors showed that *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(860--998)* results in an increase in the overall efficiency of gap repair, interpreted as an *increase* in SDSA-mediated repair ([@bib38]). This may appear in conflict with our findings which show that *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* mutation, which falls within the same deleted region, *decreases* SDSA-mediated repair. However, given the size of the deletion in the earlier study, one cannot assume that *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-∆(860--998)* disables only the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction without affecting other functions. In fact, this deletion mutation may have also removed a region that is responsible for negatively regulating the pro-SDSA functions of [Srs2](http://www.yeastgenome.org/locus/S000003628/overview), leading to the reported increase in SDSA-mediated repair. Furthermore, the work reported here and that presented in [@bib38] utilize significantly different plasmid repair assays. While the [@bib38] assay limits repair events exclusively to SDSA, the plasmid-based assay used here allows either NCO or CO pathways. The significant differences in these assays may be the underlying cause for the observed SDSA effects.

Lastly, while *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)-F891A* exhibited a clear shift from NCO to CO repair products in the plasmid-based gap repair system, this shift is not observed in the ectopic physical recombination assay. A fundamental difference between the two assays is the extent to which the broken DNA substrates may be resected. In fact, a previous publication has shown that, unlike chromosome-based recombination assays, loss of DNA resection enzymes actually improves overall repair efficiency in the plasmid-based gap repair system ([@bib17]). This is largely attributed to destruction of linearized plasmids by [Exo1](https://www.yeastgenome.org/locus/S000005559)- or [Sgs1](https://www.yeastgenome.org/locus/S000004802)-[Dna2](https://www.yeastgenome.org/locus/S000001207)-mediated long-range resection before repair can take place. We can thus infer that the transformants isolated from such plasmid-based gap repair assays correspond to a minority of repair events that have escaped extensive resection. Assuming this, the resulting D-loops may vary with respect to their size and overall stability. If [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) does, in fact, promote SDSA by dissolving extended D-loops, then the presumably longer and more stable D-loops in chromosome-based recombination assays may be refractory to [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)-mediated dissolution.

Another difference between both crossover systems is homology length. The plasmid-based crossover system has ∼400-bp homologies flanking the DSB ([@bib36], [@bib37]); in the chromosomal system ∼1400-bp and 500-bp homologies flank the DSB ([@bib22]). It is possible that the shorter homology results in different types or sizes of D-loops that are more dependent on processing by [Srs2](http://www.yeastgenome.org/locus/S000003628/overview). Unfortunately, physical chromosomal systems with homology lengths similar to the plasmid-based system do not result in measurable crossover frequencies ([@bib21]), making it difficult to test the homology length parameter.

Alternatively, as it has been proposed by [@bib45], extensively resected DNA substrates with limited homology to the donor sequence are likely channeled into the SDSA subpathway, producing exclusively NCO repair products ([@bib45]). Therefore, extensive resection of chromosomal substrates, such as the chromosomal substrates in the ectopic physical assay used here, likely commits the intermediates to the SDSA subpathway. The extensively resected chromosomes can persist until repaired through SDSA, consequently minimizing the effect [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) may have on the CO to NCO ratios. In contrast, the broken ends in the plasmid-based gap repair system may have a very short and transient window to successfully repair the gap, beyond which they become degraded and unrepairable. The minimally resected broken ends maintain the capacity to go through the dHJ pathway with the potential to still generate CO repair products as well as NCOs. Therefore, [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) activity on such substrates can still measurably sway the relative frequency of repair products.

In summary, we have identified a novel *[srs2](http://www.yeastgenome.org/locus/S000003628/overview)* mutation that, at least in part, behaves as a separation-of-function mutation that specifically inactivates the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) pro-SDSA function in the plasmid-based gap repair system while maintaining its antirecombination function. Our findings reveal the complexity of the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction and suggest a possible role for the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview)--[Rad51](http://www.yeastgenome.org/locus/S000000897/overview) interaction in SDSA/CO regulation.
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